UTHealth Houston set to enroll patients for long COVID clinical trials
Two clinical trials that will evaluate drugs, biologics, medical devices, and other therapies for long COVID that are sponsored by the National Institutes of Health (NIH) will launch at UTHealth Houston. The trials are part of the NIH Researching COVID…
CONTAIN study on convalescent plasma published in JAMA
COVID-19 convalescent plasma showed a likely benefit for patients early in the pandemic before remdesivir and corticosteroids were in use, according to results of a landmark study published in JAMA Internal Medicine that included physician-scientists at UTHealth Houston. UTHealth Houston…
Pages